Loading chat...

VA HB712

Bill

Official Source

Status

Enrolled

2/25/2026

Primary Sponsor

Otto Wachsmann

Click for details

Origin

House of Delegates

2026 Regular Regular Session

AI Summary

  • Directs the Board of Medicine to amend regulations for office-based buprenorphine treatment, requiring providers to offer counseling or referral to counseling to patients
  • Counseling must be offered when clinically necessary and mutually agreed-upon between provider and patient
  • Patients who refuse counseling cannot be denied office-based buprenorphine treatment for opioid use disorder
  • Applies to medication-assisted treatment using buprenorphine, a drug used to treat opioid addiction

Legislative Description

Office-based buprenorphine treatment; Board of Medicine to amend regulations.

Last Action

Governor's Action Deadline 11:59 p.m., April 13, 2026

3/10/2026

Committee Referrals

Education and Health2/3/2026
Health and Human Services: Health Professions1/21/2026
Health and Human Services1/13/2026

Full Bill Text

No bill text available